Taysha Gene Therapies Ownership | Who Owns Taysha Gene Therapies?
Taysha Gene Therapies Ownership Summary
Taysha Gene Therapies is owned by 25.52% institutional investors, 17.15% insiders, and 57.33% retail investors. Avoro capital advisors is the largest institutional shareholder, holding 8.00% of TSHA shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.16% of its assets in Taysha Gene Therapies shares.
TSHA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Taysha Gene Therapies | 25.52% | 17.15% | 57.33% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Avoro capital advisors | 20.00M | 8.00% | $27.80M |
| Rtw investments, lp | 18.79M | 7.51% | $26.12M |
| Fmr | 16.37M | 6.11% | $28.31M |
| Blackrock | 11.74M | 5.08% | $26.30M |
| Blackrock funding, inc. /de | 13.53M | 5.05% | $23.41M |
| Ra capital management | 10.87M | 4.35% | $15.11M |
| Vanguard group | 8.91M | 3.33% | $15.41M |
| Morgan stanley | 7.48M | 3.23% | $16.75M |
| Siren | 6.60M | 2.47% | $11.42M |
| State street | 6.47M | 2.42% | $11.20M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Octagon capital advisors lp | 2.42M | 3.44% | $17.78M |
| Tybourne capital management (hk) | 3.70M | 1.61% | $6.40M |
| Ghost tree capital | 1.25M | 0.88% | $2.80M |
| Siren | 6.60M | 0.50% | $11.42M |
| Quantum private wealth | 794.98K | 0.44% | $1.38M |
| Avoro capital advisors | 20.00M | 0.43% | $27.80M |
| Rtw investments, lp | 18.79M | 0.40% | $26.12M |
| Palo alto investors lp | 1.42M | 0.38% | $1.97M |
| Adar1 capital management | 1.07M | 0.28% | $1.48M |
| Sands capital ventures | 724.87K | 0.27% | $1.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | 18.79M | 0.40% | 10.12M |
| Blackrock | 11.74M | 0.00% | 9.15M |
| State street | 6.47M | 0.00% | 3.01M |
| Morgan stanley | 7.48M | 0.00% | 2.31M |
| Siren | 6.60M | 0.50% | 1.72M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | 2.42M | 3.44% | -8.03M |
| Adage capital partners gp | - | - | -5.00M |
| Vr adviser | - | - | -3.23M |
| Deutsche bank ag\ | 151.08K | 0.00% | -2.41M |
| Eversept partners, lp | - | - | -2.33M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.46M | 0.00% | 1.46M | $2.53M |
| First manhattan co. llc. | 28.50K | 0.00% | 28.50K | $49.30K |
| Bnp paribas arbitrage, snc | 23.64K | - | 23.64K | $40.90K |
| Ameriprise financial | 22.99K | - | 22.99K | $39.78K |
| Cibc world markets | 16.41K | 0.00% | 16.41K | $28.38K |
Sold Out
| Holder | Change |
|---|---|
| Rothschild investment | -130.00 |
| Riggs asset managment | -198.00 |
| Clear street markets | -424.00 |
| Cwm | -499.00 |
| Global retirement partners | -1.01K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 12 | -90.63% | 63,845,739 | -61.79% | 25 | 0.66% | 7 | -90.41% | 1 | -96.00% |
| Dec 31, 2024 | 126 | 5.00% | 167,074,710 | 6.47% | 62 | 1.82% | 72 | -4.00% | 25 | 56.25% |
| Sep 30, 2024 | 120 | 12.15% | 156,916,875 | -0.74% | 58 | 1.25% | 75 | 15.38% | 16 | -11.11% |
| Jun 30, 2024 | 107 | -3.60% | 158,086,768 | 12.80% | 68 | 1.86% | 65 | -1.52% | 18 | -28.00% |
| Mar 31, 2024 | 111 | 24.72% | 140,142,393 | 7.72% | 60 | 0.48% | 66 | 13.79% | 25 | 108.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 6.48M | 3.16% | - |
| Fidelity Growth Compy Commingled Pl S | 5.35M | 2.61% | - |
| Vanguard Total Stock Mkt Idx Inv | 4.85M | 2.36% | - |
| Vanguard US Total Market Shares ETF | 4.46M | 2.17% | - |
| iShares Russell 2000 ETF | 4.55M | 2.12% | 2.23K |
| Fidelity Growth Company Fund | 4.22M | 2.06% | - |
| Fidelity Select Biotechnology | 3.41M | 1.66% | -401.67K |
| Polar Capital Biotech S Inc | 3.00M | 1.40% | - |
| SPDR® S&P Biotech ETF | 2.68M | 1.31% | -16.32K |
| Xtrackers MSCI World Swap ETF 1C | 2.47M | 1.20% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 30, 2025 | Manning Paul B | - | Buy | $2.06M |
| Jun 27, 2024 | Manning Paul B | - | Buy | $3.00M |
| Nov 17, 2023 | Manning Paul B | - | Buy | $163.00K |
| Aug 24, 2023 | Alam Kamran | Chief Financial Officer | Sell | $76.89K |
| Aug 16, 2023 | Manning Paul B | - | Buy | $14.82M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | - |
| 2024 Q2 | 1 | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 1 | - |
TSHA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools